A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

NCT02135276 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

End Stage Renal Disease

Interventions

DRUG: eravacycline

Sponsor

Tetraphase Pharmaceuticals, Inc